STAT Plus 7 things to know about Aimmunes peanut allergy therapy ahead of a pivotal FDA meeting
STAT Plus: 7 things to know about Aimmune’s peanut allergy therapy ahead of a pivotal FDA meeting
04:35 EDT 4 Sep 2019 |
STAT
Ahead of a pivotal FDA meeting, here are seven things to know about Aimmune’s peanut allergy therapy.
More From BioPortfolio on "STAT Plus: 7 things to know about Aimmune’s peanut allergy therapy ahead of a pivotal FDA meeting"